Lori Long

Results from a phase II study of bevacizumab and erlotinib in subjects with advanced hereditary leiomyomatosis and renal cell cancer (HLRCC) or sporadic papillary renal cell cancer.

Ramaprasad Srinivasan, Sandeep Gurram, Munjid Al Harthy et al. · Journal of Clinical Oncology · 2020 · 94 citations

Medicine, Oncology, Pharmacology +17

Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study

Michael Ahdoot, Amir H. Lebastchi, Lori Long et al. · European Urology Oncology · 2021 · 47 citations · Full text

Medicine, Radiology, Urology +14

Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance

Luke O’Connor, Alex Z. Wang, Nitin Yerram et al. · European Urology Oncology · 2020 · 28 citations · Full text

Medicine, Radiology, Urology +17

Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies

Liqun Jiang, Aparna Pallavajjala, Jialing Huang et al. · Journal of Molecular Diagnostics · 2021 · 24 citations

Medicine, Hematology, Molecular Genetics +17

PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance

Alex Z. Wang, Luke P. Oonnor, Nitin Yerram et al. · The Journal of Urology · 2020 · 18 citations · Full text

Medicine, Oncology, Urology +9